Allergan Profit Margins 2006-2018 | AGN

Current and historical gross, operating and net profit margins for Allergan (AGN) over the last 10 years. The current net profit margin for Allergan (AGN) as of March 31, 2018 is -11.94%.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.011B $15.941B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $23.927B 6.26
Mylan (MYL) United Kingdom $18.516B 7.83
Dr Reddy's Laboratories (RDY) India $4.947B 29.53
Supernus Pharmaceuticals (SUPN) United States $2.833B 35.52
Akorn (AKRX) United States $2.111B 10.47
AxoGen (AXGN) United States $1.901B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.813B 3.06
Assembly Biosciences (ASMB) United States $0.879B 0.00
Homology Medicines (FIXX) United States $0.781B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.763B 71.17
CymaBay Therapeutics (CBAY) United States $0.758B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.735B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.611B 0.00
Voyager Therapeutics (VYGR) United States $0.589B 0.00
Corium (CORI) United States $0.289B 0.00
Teligent (TLGT) United States $0.217B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.138B 0.00
Sol-Gel Technologies (SLGL) Israel $0.129B 0.00
Versartis (VSAR) United States $0.074B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.068B 0.00
Aevi Genomic Medicine (GNMX) United States $0.053B 0.00
Evoke Pharma (EVOK) United States $0.042B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.029B 0.00
Agile Therapeutics (AGRX) United States $0.018B 0.00
Acasti Pharma (ACST) Canada $0.014B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00